Insider trades

Mark Bachleda, Director of Lyell Immunopharma LYEL, has filed 1 purchase and 0 sales on the open market. The latest trade was on 06/10.

Mark Bachleda

Director
First filing
23/02/28
Trades
4 trades
Buys / sales
1 / 0
12-month net buying
No record
Last trade
06/10

Trading activity

Transactions

Trade type
Open-market buy23/03/1623/03/2011,000 sh$2.25$24,750No record